Publication | Closed Access

Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro

Ascorbic AcidAntineoplastic ActivityBreast OncologyOncogenic AgentMedicinePharmacologyVitamin CBreast CancerAnti-cancer AgentCancer TreatmentOncologyCell BiologyCancer ResearchTumor Biology